Rodman & Renshaw Initiates Coverage on Kyverna Therapeutics (NASDAQ:KYTX)
Equities researchers at Rodman & Renshaw began coverage on shares of Kyverna Therapeutics (NASDAQ:KYTX – Get Free Report) in a research report issued to clients and investors on Wednesday, Marketbeat.com reports. The firm set a “buy” rating and a $16.00 price target on the stock. Rodman & Renshaw’s price target points to a potential upside […]
More Stories
Durango Resources (CVE:DGO) Trading Up 28.6% – Should You Buy?
Durango Resources Inc. (CVE:DGO – Get Free Report) shot up 28.6% during mid-day trading on Saturday . The company traded...
Simplify Intermediate Term Treasury Futures Strategy ETF (TYA) to Issue Dividend of $0.07 on December 31st
Simplify Intermediate Term Treasury Futures Strategy ETF (BATS:TYA – Get Free Report) declared a dividend on Friday, December 20th,NASDAQ Dividends...
Invesco Short Duration Bond ETF (ISDB) to Issue Dividend of $0.12 on December 27th
Invesco Short Duration Bond ETF (BATS:ISDB – Get Free Report) declared a dividend on Friday, December 20th,NASDAQ Dividends reports. Stockholders...
Simplify NEXT Intangible Core Index ETF (NXTI) To Go Ex-Dividend on December 23rd
Simplify NEXT Intangible Core Index ETF (BATS:NXTI – Get Free Report) declared a dividend on Friday, December 20th,NASDAQ Dividends reports....
VanEck Morningstar Wide Moat Value ETF (NYSEARCA:MVAL) Announces $0.31 Dividend
VanEck Morningstar Wide Moat Value ETF (NYSEARCA:MVAL – Get Free Report) declared a dividend on Friday, December 20th,NASDAQ Dividends reports....
First Bancshares Inc. (Bellevue, OH) Declares Quarterly Dividend of $0.33 (OTCMKTS:FIBH)
First Bancshares Inc. (Bellevue, OH) (OTCMKTS:FIBH – Get Free Report) declared a quarterly dividend on Thursday, December 19th,NASDAQ Dividends reports....